Clinical and genetic correlates of islet-autoimmune signatures in juvenile-onset type 1 diabetes

被引:26
|
作者
Claessens, Laura A. [1 ]
Wesselius, Joris [1 ]
van Lummel, Menno [1 ]
Laban, Sandra [1 ]
Mulder, Flip [2 ]
Mul, Dick [3 ]
Nikolic, Tanja [1 ]
Aanstoot, Henk-Jan [3 ]
Koeleman, Bobby P. C. [2 ]
Roep, Bart O. [1 ,4 ]
机构
[1] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands
[2] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands
[3] Diabeter, Ctr Pediat & Adolescent Diabet Care & Res, Rotterdam, Netherlands
[4] City Hope Natl Med Ctr, Dept Diabet Immunol, Diabet & Metab Res Inst, Beckman Res Inst,Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
关键词
Autoimmune disease; Autoreactive T cells; Disease endotypes; Disease heterogeneity; Epitope spreading; Immunotherapy; Islet autoantigen; Patient heterogeneity; Personalised medicine; Precision medicine; GENOME-WIDE ASSOCIATION; RISK SCORE; SUSCEPTIBILITY; CELL; DISEASE; AUTOANTIBODIES; METAANALYSIS; PREDICTION; CHILDREN; LOCI;
D O I
10.1007/s00125-019-05032-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis Heterogeneity in individuals with type 1 diabetes has become more generally appreciated, but has not yet been extensively and systematically characterised. Here, we aimed to characterise type 1 diabetes heterogeneity by creating immunological, genetic and clinical profiles for individuals with juvenile-onset type 1 diabetes in a cross-sectional study. Methods Participants were HLA-genotyped to determine HLA-DR-DQ risk, and SNP-genotyped to generate a non-HLA genetic risk score (GRS) based on 93 type 1 diabetes-associated SNP variants outside the MHC region. Islet autoimmunity was assessed as T cell proliferation upon stimulation with the beta cell antigens GAD65, islet antigen-2 (IA-2), preproinsulin (PPI) and defective ribosomal product of the insulin gene (INS-DRIP). Clinical parameters were collected retrospectively. Results Of 80 individuals, 67 had proliferation responses to one or more islet antigens, with vast differences in the extent of proliferation. Based on the multitude and amplitude of the proliferation responses, individuals were clustered into non-, intermediate and high responders. High responders could not be characterised entirely by enrichment for the highest risk HLA-DR3-DQ2/DR4-DQ8 genotype. However, high responders did have a significantly higher non-HLA GRS. Clinically, high T cell responses to beta cell antigens did not reflect in worsened glycaemic control, increased complications, development of associated autoimmunity or younger age at disease onset. The number of beta cell antigens that an individual responded to increased with disease duration, pointing to chronic islet autoimmunity and epitope spreading. Conclusions/interpretation Collectively, these data provide new insights into type 1 diabetes disease heterogeneity and highlight the importance of stratifying patients on the basis of their genetic and autoimmune signatures for immunotherapy and personalised disease management.
引用
收藏
页码:351 / 361
页数:11
相关论文
共 50 条
  • [21] Juvenile case with the coexistence of maturity-onset diabetes of the young 1 and later-onset latent autoimmune diabetes in youth
    Yoshida, Kei
    Urakami, Tatsuhiko
    Mine, Yusuke
    Kuwabara, Remi
    Morioka, Ichiro
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (04) : 1010 - 1013
  • [22] Intrafamilial spread of enterovirus infections at the clinical onset of type 1 diabetes
    Salvatoni, Alessandro
    Baj, Andreina
    Bianchi, Giuliana
    Federico, Giovanni
    Colombo, Martina
    Toniolo, Antonio
    PEDIATRIC DIABETES, 2013, 14 (06) : 407 - 416
  • [23] Onset of autoimmune type 1 diabetes during pregnancy: Prevalence and outcomes
    Wucher, Helene
    Lepercq, Jacques
    Timsit, Jose
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 24 (04) : 617 - 624
  • [24] Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study
    Beyerlein, Andreas
    Bonifacio, Ezio
    Vehik, Kendra
    Hippich, Markus
    Winkler, Christiane
    Frohnert, Brigitte I.
    Steck, Andrea K.
    Hagopian, William A.
    Krischer, Jeffrey P.
    Lernmark, Ake
    Rewers, Marian J.
    She, Jin-Xiong
    Toppari, Jorma
    Akolkar, Beena
    Rich, Stephen S.
    Ziegler, Anette-G
    JOURNAL OF MEDICAL GENETICS, 2019, 56 (09) : 602 - 605
  • [25] Type 1 diabetes associated with Hashimoto's thyroiditis and juvenile rheumatoid arthritis: a case report with clinical and genetic investigations
    Nagy, Katalin H.
    Lukacs, Krisztina
    Sipos, Peter
    Hermann, Robert
    Madacsy, Laszlo
    Soltesz, Gyula
    PEDIATRIC DIABETES, 2010, 11 (08) : 579 - 582
  • [26] Genetic Mechanisms Highlight Shared Pathways for the Pathogenesis of Polygenic Type 1 Diabetes and Monogenic Autoimmune Diabetes
    Johnson, Matthew B.
    Cerosaletti, Karen
    Flanagan, Sarah E.
    Buckner, Jane H.
    CURRENT DIABETES REPORTS, 2019, 19 (05)
  • [27] The role of islet autoantigen-specific T cells in the onset and treatment of type 1 diabetes mellitus
    Yue, Mengmeng
    He, Xianzhen
    Min, Xinwen
    Yang, Handong
    Xu, Hao
    Wu, Wenwen
    Zhong, Jixin
    Mei, Aihua
    Chen, Jun
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] Overlap of Genetic Susceptibility to Type 1 Diabetes, Type 2 Diabetes, and Latent Autoimmune Diabetes in Adults
    Basile, Kevin J.
    Guy, Vanessa C.
    Schwartz, Stanley
    Grant, Struan F. A.
    CURRENT DIABETES REPORTS, 2014, 14 (11) : 1 - 7
  • [29] Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies
    Winkler, Christiane
    Schober, Edith
    Ziegler, Anette-Gabriele
    Holl, Reinhard W.
    PEDIATRIC DIABETES, 2012, 13 (04) : 301 - 306
  • [30] Found in Translation: A Type 1 Diabetes Genetic Risk Score Applied to Clinical Diagnosis
    Florez, Jose C.
    DIABETES CARE, 2016, 39 (03) : 330 - 332